-
The Three-Step Method and Other Factors in Inventiveness Analyses
In this issue, we briefly discuss a 2021 patent invalidation case, in which the Supreme People's Court clarifies how inventiveness analyses, using the Three-Step Method1 and considering Other Factors (similar to Secondary Considerations in U.S. practice), should be conducted.The following is a literal translation of the Supreme Court's own headnote for the case in the
2022-11-25 -
Highlights from the 2021 Annual Report by China National Intellectual Property Administration
The China National Intellectual Property Administration (CNIPA) has recently released its 2021 Annual Report. We now summarize some of the key information and statistics regarding patents in the Report for you to have an easy overview of the current state of Chinese patent application and prosecution. Please note that there are three types of patents in China, i.e. invention&
2022-08-05 -
Highlights from the Annual Report on IP Cases by the Supreme People’s Court
On March 1, 2022, the Intellectual Property Court of the Supreme People's Court (“the IP Court” of the “SPC”) of China released its 2021 Annual Report. We now provide you with the following key data and main characteristics of the different types of cases in the Report.Key DataCase LoadIn 2021, the IP Court continued to see significant increases in both newly receiv
2022-04-25 -
China Joins the Hague System of Industrial Designs
As the Year of the Tiger begins, WIPO announced the exciting news thatChina has decided to join the Hague System for the International Registrationof Industrial Designs, to be effective from May 5, 2022. With Korea, Japan, theUnited States and United Kingdom all joined in recent years, China’s joiningmeans that the contracting parties to the Hague S
2022-02-25 -
Patent Term Adjustment and Drug Patent Term Extension after Amendment to Chinese Patent Law
As we reported in our October 2020 and May 2021 Newsletters, the Fourth Amendment to Chinese Patent Law has become effective from June 1, 2021. In this regard, we want to draw your attention to the following two provisions in the new Patent Law.Article 42.2 For patents granted after four (4) years from the application date and three (3) years from date of request fo
2021-06-11
Our professionals include some of the most experienced and committed practitioners in their profession. Our attorney’s cross-domain specializations allow for seamless customized intellectual property solutions for clients’ needs.
Our people are the key to providing the full range of service capabilities our clients need by working together as integrated, multidisciplinary teams with each member drawing from a unique set of talents.
We invite you to review the wide range of their qualifications and capabilities.
Share
-
Beijing Office
-
Hong Kong Office (Associated)
-
Singapore Office (Associated)
-
Washington D.C. Office (Associated)
-
Tokyo Office (Associated)
-
Munich Office (Associated)
Tel: +86-10-6657 6688
Fax: +86-10-6657 8088
E-mail: sinda@chinasinda.com Backup e-mail: (from May 18, 2021) sinda@chinasinda.com.cn
11/F, Tower B, Focus Place
19 Financial Street
Beijing 100033, P.R. China
Tel: +852-21109911
Fax: +852-21109973
E-mail: mail@csiphk.com; patent@csiphk.com; hk@chinasinda.com
Suite 3301 One Exchange Square
Central, Hong Kong
Tel: +65-62228501
Fax: +65-62228505
E-mail: weilin.zhang@chinasinda.com Backup emails: mail@chinasinda.sg zhang_weilin@outlook.com
133 Cecil Street
#12-01A Keck Seng Tower
Singapore 069535
Suite 205
17B Firstfield Road
Gaithersburg, MD 20878
USA
Park Court Shibuya the Tower 1104
1-12 Udagawacho, Shibuya-ku,
Tokyo, 1500042 Japan
Tel: +49-89-90405060
Fax: +49-89-90405066
E-mail: munich@chinasinda.com
Regus Business Center
Landsberger Str. 302
80687, Munich, Germany
